Health Care

#GPnews: Hope that new blood test could boost prostate cancer survival

#GPnews: Hope that new blood test could boost prostate cancer survival”

By looking for cancer DNA in blood samples, researchers were able to identify men with defective BRCA genes who were likely to benefit from a class of drugs called PARP inhibitors.

The study also found that the blood test could pick up the first signs that the tumour is evolving to become resistant to treatment, potentially speeding up efforts to try new lines of attack. Precision medicine or personalized medicine concerns the customization of healthcare.

Lynparza - abandoned at one stage by AstraZeneca but revived by CEO Pascal Soriot when he took over in 2012 - became the first PARP drug to reach the market when it won US approval for ovarian cancer at the end of 2014. In relation to the new research, medical laboratory testing could select the appropriate therapy for an individual person based on a given person's individual genetic make-up and particular physical characteristics.

More than 40,000 men in the United Kingdom are diagnosed with prostate cancer every year, making it the most common male cancer. This type of cancer describes the development of cancer in the prostate (a gland in the male reproductive system).

The men were taking part in a phase 2 clinical trial where they were treated with olaparib (Lynparza), a targeted cancer drug called a PARP inhibitor.

A new 3-in-1 blood test could revolutionise the treatment of prostate cancer, say scientists, and help pave the way for personalised patient treatment. Hence the need for a test to determine which individual patients would benefit and which would not.

These patients survived and average of 17 months compared with 10 months for those whose cancer DNA levels remained high.

They found that the cells acquired genetic changes that cancelled out the DNA fix defects making them susceptible to the drug.

"Blood tests for cancer promise to be truly revolutionary".

Bono said the three-in-one test may be used in the future to help doctors choose treatment for prostate cancer patients, check if the treatment is working, and track the cancer in the longer term. They found that cancer cells had acquired new genetic changes that canceled out the original errors in DNA repair-particularly in the genes BRCA2 and PALB2-that had made the cancer susceptible to olaparib in the first place.

'We think it could be used to make clinical decisions about whether a Parp inhibitor is working within as little as four to eight weeks of starting therapy.

In the future, the researchers believe the test could be used both before and after treatment.

"This is another important example where liquid biopsies - a simple blood test as opposed to an invasive tissue biopsy - can be used to direct and improve the treatment of patients with cancer". "That is why Prostate Cancer UK is investing so heavily in this area, including supporting this research released today".



Like this

loading...

Latest


19 June 2017
Tom Brady wants to play a National Football League game in China
The Patriots will open up their season on Thursday, Sept. 7 when they host the Kansas City Chiefs at 8:30 p.m. With his career coming closer to a close, Brady wants a chance to play that game finally.

19 June 2017
Jackson police: Boy shot in head
WAPT reported police eventually took Jackson into custody following a traffic stop, while Bradley was captured at Club Elite. He was rushed to the University of Mississippi Medical Center where he is now in very serious critical condition.

19 June 2017
Matinas BioPharma Holdings Inc
This company shares are 145.61% off its target price of $7 and the current market capitalization stands at $249.49M. Matinas BioPharma Holdings (NASDAQ:MTNB) last released its quarterly earnings results on Tuesday, May 16th.

19 June 2017
May meets London blaze victims amid rising anger
The 91-year-old monarch said it is "difficult to escape a very somber mood" on what is normally a day of celebration. London Fire Brigade said the service has been "overwhelmed" by the support it has received from all over the world.

19 June 2017
US shoots down Syrian Air Force fighter
Share with Us - We'd love to hear eyewitness accounts, the history behind an article, and smart, constructive criticism. A Pentagon spokesman says the US had not shot down a Syrian regime aircraft before Sunday's confrontation.

19 June 2017
A minute silence for the victims of the Grenfell Tower fire
It includes 30 deaths that already have been confirmed, and reports of people who are missing and presumed to have been killed. Hundreds have been left homeless, putting more pressure on officials in a city plagued by a chronic housing shortage.

19 June 2017
In Trump tweets, 'witch hunt' now all the rage
Trump also attacked the media Friday morning. "That was his promise and that's exactly what we're doing". It was not clear why he attributed the report to an Federal Bureau of Investigation leak.

19 June 2017
Man plows van into crowd by London mosque; 10 injured
Omar said it had been "an attack on Muslims practicing religion" - and one which occurred during the holy month of Ramadan. This is a clear hate crime. "We've got to listen to local leaders about what more it is that we can do".

19 June 2017
Everton sign Nathangelo Markelo and add to title-winning U23 squad
Everton have announced the signing of teenage defender Nathangelo Markelo on a three-year deal from FC Volendam . I decided immediately that I wanted to come to Everton .

19 June 2017
One dead, 10 injured after driver plows into crowd outside London mosque
That attack came in the wake of a suicide bombing outside an Ariana Grande concert in Manchester last month that killed 22. Police declared it a terrorist incident within eight minutes". "Some big van ... crushing the people in the mosque".